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Discrimination of Stem Cell Status 
after Subjecting Cynomolgus 
Monkey Pluripotent Stem Cells to 
Naïve Conversion
Arata Honda1,2, Yoshihiro Kawano1, Haruna Izu1, Narantsog Choijookhuu3, Kimiko Honsho1, 
Tomonori Nakamura4,5, Yukihiro Yabuta4,5, Takuya Yamamoto6,7,8, Yasuhiro Takashima6, 
Michiko Hirose2, Tadashi Sankai9, Yoshitaka Hishikawa3, Atsuo Ogura2 & Mitinori Saitou4,5,6,7
Experimental animal models have played an indispensable role in the development of human induced 
pluripotent stem cell (iPSC) research. The derivation of high-quality (so-called “true naïve state”) 
iPSCs of non-human primates enhances their application and safety for human regenerative medicine. 
Although several attempts have been made to convert human and non-human primate PSCs into a truly 
naïve state, it is unclear which evaluation methods can discriminate them as being truly naïve. Here we 
attempted to derive naïve cynomolgus monkey (Cm) (Macaca fascicularis) embryonic stem cells (ESCs) 
and iPSCs. Several characteristics of naïve Cm ESCs including colony morphology, appearance of naïve-
related mRNAs and proteins, leukaemia inhibitory factor dependency, and mitochondrial respiration 
were confirmed. Next, we generated Cm iPSCs and converted them to a naïve state. Transcriptomic 
comparison of PSCs with early Cm embryos elucidated the partial achievement (termed naïve-like) of 
their conversion. When these were subjected to in vitro neural differentiation, enhanced differentiating 
capacities were observed after naïve-like conversion, but some lines exhibited heterogeneity. The 
difficulty of achieving contribution to chimeric mouse embryos was also demonstrated. These results 
suggest that Cm PSCs could ameliorate their in vitro neural differentiation potential even though they 
could not display true naïve characteristics.
Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) have been evaluated for several charac-
teristics to confirm their pluripotency. Improvements in quality and evaluations of their stemness are important 
for developing medical applications and chimeric animal production. The PSC state can be distinguished by 
two terminological definitions: naïve and primed1. The naïve pluripotent state remains similar to that of the 
inner cell mass from mouse pre-implantation blastocysts2, and it can be induced by the generation of mouse 
ESCs or reprogramming of mouse somatic cells to form iPSCs3. On the other hand, the primed pluripotent state 
can be defined as having the characteristics of epiblast stem cells (EpiSCs), which are generated from mouse 
5.5–7.5 days post coitus (dpc) post-implantation epiblasts4,5 or epiblast like cells (EpiLCs), which are similar to 
pre-gastrulating epiblasts6,7. Although naïve PSCs can effectively contribute to chimeras when introduced into 
pre-implantation embryos and can differentiate into germ cells in vivo and in vitro, primed PSCs show a restricted 
capacity for this behaviour8–10. Other than rodents, almost all mammals including human-derived PSCs show 
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a primed pluripotent state. The successful conversion of primed-state PSCs into a naïve state might enable the 
derivation of high-quality human PSCs.
Primed PSCs from several animal species have been attempted to convert into a naïve state11–13. Properties 
of a naïve state are a domed-shape colony morphology, leukaemia inhibitory factor (LIF) dependency, abil-
ity to use mitochondrial respiration, pluripotent transcriptomal circuitry, transcriptional status resembling 
pre-implantation epiblasts, and efficient ability to contribute to chimeric embryos with subsequent germline 
transmission. However, such PSCs failed to fulfil these conditions (especially showing transcriptomal similarity 
to pre-implantation epiblasts); therefore, they should be termed not “naïve”, but “naïve-like”. These exhibit several 
naïve-specific characteristics but fail to acquire a transcriptome status resembling pre-implantation epiblasts and 
can apparently be distinguished from primed-state PSCs (see Supplementary Table S1). However, many types of 
PSCs in several mammalian species, which researchers had hoped to convert into a true naïve state, could not 
fulfil these naïve properties. For humans, it is difficult to evaluate the ability of PSCs to contribute to chimeras 
because of technical and ethical concerns, so evaluating gene transcriptional networks before and after naïve 
conversion has been achieved is recognized as one of the most precise means of checking on “true” naïve pluri-
potency14. Actually, the overexpression of KLF2 and NANOG when cultured in appropriate conditions provided 
primed-state human ESCs with putative naïve pluripotency, and these showed significant overlap with mouse 
ESCs and human pre-implantation embryos in terms of their transcriptome status15,16. To mitigate the ethical 
concerns in using human PSCs, translational research using non-human primates might provide precise indi-
cators for human PSC application. Naïve-like conversion of non-human primate ESCs17 and iPSCs18 has been 
demonstrated. Both types of naïve-like converted PSCs could contribute to chimeric embryos but only in minor 
ways via unknown species-specific features despite the successful demonstration of some naïve characteristics. To 
develop efficient human translational research, it will be necessary to evaluate and compare detailed characteris-
tics before and after achieving naïve conversion of ESCs and iPSCs in non-human primates.
In this report, we have attempted to generate naïve ESCs and iPSCs from cynomolgus monkey (Cm) (Macaca 
fascicularis) cells by subjecting them to a naïve conversion system that we developed for rabbit ESCs with some 
modifications. Transcriptome evaluations with pre- and post-implantation Cm embryos7 clearly revealed the 
precise status of the PSCs: not naïve but naïve-like. However, they showed enhanced potential for neural differ-
entiation in vitro after conversion. This study offers valuable pointers for deriving true naïve PSCs while avoiding 
irrelevant or misleading evidence of naïve-like features.
Results
Subjecting Cm ESCs to modified rabbit naïve conversion. A Cm ESC line, CMK6, was first subjected 
to methods for naïve conversion using a system that had been developed for rabbit PSCs12,13 with some modifica-
tions. This protocol uses overexpression of the OCT3/4 gene by the EF1α promoter in rabbit PSCs, which are cul-
tured in a medium containing knock-out serum replacement (KSR), and three chemical inhibitors: CHIR99021, a 
glycogen synthase kinase (GSK)-3β inhibitor; forskolin, an adenylyl cyclase activator; kenpaullone, a GSK-3β and 
cyclin-dependent kinase inhibitor; as well as human LIF. This medium is termed K3cL. Kenpaullone is known to 
express strong reprogramming activity, not only as a GSK-3β or cell cycle inhibitor, but it also has uncharacterized 
desirable effects19. When a Cm ESC line, CMK6, was cultured in K3cL medium without transgenic overexpres-
sion of OCT3/4—as used for rabbit PSC naïve conversion—almost all the colonies differentiated and disappeared 
within five passages. This result indicated the requirement of exogenous trigger(s) to maintain pluripotency at an 
initial phase of naïve conversion. To control and monitor such exogenous triggers, the plasmid vectors PB-tet-
hKLF2-Venus and PB-tet-hNANOG-Venus were transfected into CMK6 cells and cultured with doxycycline 
(Dox) as reported by Takashima et al.15 and Theunissen et al.16. PB-EOS-GFP-puroR20 and PB-CAG-Su9DsRediN 
were also transfected to confirm pluripotency and the ability to contribute to chimeric offspring, respectively. 
The EOS-containing vector also has a reverse tetracycline transactivator (rtTA) cassette for enhanced expression 
of the tet promoter21. Two weeks after transfection and drug selection using primed culture medium containing 
basic fibroblast growth factor (bFGF) and KSR in the presence of Dox, almost all the colonies showed Venus 
and DsRed signals (Fig. 1b). When a CMK6 line overexpressing KLF2 and NANOG was cultured in t (titrated) 
2i (CHIR99021 and a MEK inhibitor, PD0325901) with LIF medium in the presence of Dox (t2iLD) according 
to Takashima et al.15, Cm ESCs could not proliferate in the same way as human naïve ESCs, and some differenti-
ated colonies appeared (see Supplementary Fig. S1). This result suggests that Cm ESCs could not be maintained 
by these conditions even when exogenous KLF2 and NANOG were overexpressed, as seen with human naïve 
conversion. However, after transfection with KLF2 and NANOG as exogenous triggers, transgenic CMK6 cells 
could be maintained in K3cL medium with Dox (K3cLD) with the appearance of some of differentiated (cobble-
stone-like) colonies (see Supplementary Fig. S1). To prevent the appearance of differentiated colonies, a BRAF 
inhibitor, SB590885, and a PKC inhibitor, Gö6983, which are known to be effective for deriving naïve human 
PSCs in conditions overexpressing KLF2 and NANOG, were added to K3cLD (now termed K5cLD medium). 
When this K5cLD medium was used, colonies become tightly packed and dome-shaped, as seen in mouse ESCs 
(Fig. 1b). These cells could be propagated by single cell dissociation using trypsin digestion even in the absence 
of a rho-associated protein kinase inhibitor. In the presence of Dox, a bright Venus signal that was tandemly 
expressed with exogenous hKLF2 and NANOG appeared, and undifferentiated colonies could be maintained for 
over half a year. At 24 days after conversion by Dox treatment, domed colonies could be maintained without Dox. 
In the absence of Dox, faint green fluorescent protein (GFP) signals derived from the EOS-GFP vector appeared, 
as seen in human PSCs15 (Fig. 1b). However, some differentiated colonies appeared and gradually increased after 
Dox withdrawal (see Supplementary Fig. S2). To maintain their undifferentiated status without any differentiated 
cells, culture medium supplemented with Dox (K5cLD) was used. Exogenous KLF2 and NANOG were both 
expressed in the presence of Dox and silenced in its absence (Fig. 1e). We have provisionally termed this domed-
shaped stem cell status to be “naïve-like”. These naïve-like CMK6 cells were immunochemically positive for 
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Figure 1. Naïve-like conversion of cynomolgus monkey (Cm) ESCs. (a,b) Schematic representation 
of time schedule (a) and representative images (b) of the naïve-like conversion of a Cm ESC line, CMK6, 
observed at different stages during naïve-like conversion. AP, alkaline phosphatase activity. Scale bar = 100 μ 
m. (c) Immunocytochemical analysis of the CMK6 cell line that had been converted into a naïve-like state, 
using antibodies (OCT3/4, NANOG, SOX2, REX1, KLF4, and KLF17) directed against markers of naïve 
pluripotency-related proteins. Scale bar = 50 μ m. (d) RT–qPCR for naïve pluripotency-related transcripts before 
(closed bars: primed) and after (open bars: naïve-like) naïve-like conversion. Error bars indicate the standard 
deviation (S.D.) *P < 0.05; **P < 0.01. (e) RT–qPCR confirmation of the expression and silencing of Exo-
hNANOG and Exo-hKLF2 in the presence (+ ) or in the absence (−) of Dox. (f) Normal number (2n = 42) of 
metaphase chromosomes confirmed in naïve-like converted CMK6 cells at passage 12. (g) Teratoma formation 
by naïve-like converted CMK6. Various tissues of the three germ layer origins are identified: neurons stained 
with haematoxylin and eosin (ectoderm), hyaline cartilage stained with Toluidine blue (mesoderm), and goblet 
cells stained with Alcian blue (endoderm). Scale bar = 100 μ m.
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naïve pluripotency-related marker proteins (Fig. 1c). Naïve-like CMK6 cells were strongly positive for OCT3/4, 
NANOG, and SOX2, but weakly positive for REX1, KLF4, and KLF17. However, some heterogeneity could be 
observed in KLF4 expression. The increased expression of OCT3/4, GDF3, DNMT3L, DPPA5, SOX2, TBX3, 
TFCP2L1, CDH1, KLF4, and KLF5, which are candidate genes for maintaining naïve pluripotency, was con-
firmed by quantitative reverse transcription polymerase chain reaction (RT–qPCR; Fig. 1d). However, unchanged 
or reduced expressions were confirmed in endo-KLF2, endo-NANOG, BCL2, and ESRRB. The addition of Dox 
to prevent the appearance of differentiated colonies could substitute for Endo-KLF2 and Endo-NANOG and 
potentially compensate for naïve-related transcriptional circuitry (Fig. S2). Normal karyotypes (Fig. 1f and 
Supplementary Table S2) and typical teratoma-forming activity (Fig. 1g and Supplementary Fig. S3) were verified 
after 10 passages in the naïve culture conditions. As reported by Takashima et al.15, naïve-like CMK6 cells reverted 
to a conventional flat ESC colony morphology by changing the K5cLD medium to the primed culture medium 
(bFGF/KSR) (see Supplementary Fig. S4). These observations imply that Cm ESCs were successfully converted 
into a naïve-like state without losing their pluripotency.
Effectiveness of LIF and Dox for maintaining their pluripotency in Cm ESCs. Naïve-like converted 
Cm ESCs could be maintained in the absence of bFGF. If these cells had a true naïve state, strict sensitivity to LIF 
should have been shown22. Additionally, we needed to address the effects of Dox on their pluripotency. To test 
these effects, LIF and Dox were removed from K5cLD medium. Seven days after LIF and Dox removal (K5c), 
the colony morphology changed into a cobble-stone appearance, and the faint EOS-GFP signals disappeared 
completely (Fig. 2a). Semi-quantitative RT–PCR demonstrated that the expression of pluripotency-linked genes 
disappeared or was decreased by this treatment without SOX2 or TBX3 (Fig. 2b). To evaluate the effect of LIF on 
naïve-like status, the EOS vector, known as an indicator of pluripotency, was applied. Because the EOS vector 
drives the expression of GFP and puroR genes via their EOS promoter, naïve-like Cm ESCs were cultured with 
puromycin in the presence or absence of LIF. In spite of the absence of Dox (K5cL medium), more than 80% 
of cells survived; however, almost all of the naïve-like Cm ESCs died within a week after the withdrawal of LIF 
(Fig. 2c,d). These results suggest that LIF and Dox together acted in the maintenance of pluripotency in Cm ESCs 
and also demonstrated that removing both of them from the cultures induced rapid loss of their undifferentiated 
status.
Acquisition of mitochondrial respiration by naïve-like conversion. Human naïve and primed ESCs 
exhibit distinct metabolic profiles, and they convert markedly, with changes in mitochondrial respiration and 
glycolysis23,24. It is known that this primed-to-naïve switch leads from an exclusively glycolytic metabolism in the 
primed state to both glycolytic and mitochondrial respiration in the naïve state. To examine the functional conse-
quences of such altered metabolic properties, several characteristics were evaluated. Electron microscopy before 
and after naïve-like conversion showed that in the primed state, the Cm ESCs had many elongated mitochondria 
with a dense matrix, in contrast to the mitochondria of naïve-like converted Cm ESCs, which are round to oval, 
displaying sparse and irregular cristae and an electron-lucent matrix (Fig. 2e,f). RT–qPCR demonstrated that 
the mRNA expression levels of mitochondrial function-related genes were increased significantly by naïve-like 
conversion of Cm ESCs (Fig. 2g). When an inhibitor of glycolysis, 2-deoxyglucose (2DG), was added, the 
primed-state Cm ESCs disappeared because of their exclusive dependency on glycolytic metabolism (Fig. 2h,i). 
On the other hand, naïve-like converted Cm ESCs persisted and formed alkaline phosphatase (AP)-positive col-
onies due to the utilization of acquired mitochondrial respiration. Moreover, Cm CMK6 cells were examined a 
basal oxygen consumption rate (OCR) and we found that it was substantially higher in naïve-like CMK6 than in 
primed-state cells (Fig. 2j). These results suggest that the primed-state Cm ESCs acquired the capacity for mito-
chondrial respiration by naïve-like conversion.
Naïve-like conversion of Cm iPSCs. To compare ESCs and iPSCs before and after naïve-like con-
version, Cm iPSC lines were derived from freshly collected liver and stomach of a female Cm foetus (see 
Supplementary Fig. S5). Episomal plasmid vectors bearing OCT3/4, SOX2, KLF4, LIN28, L-MYC, and p53 small 
hairpin RNA were transduced into cultured somatic cells, and then iPSC generation was carried out. The fre-
quency of derivation of iPSC lines was determined from the liver (termed iPS-L) giving 12 lines (0.024%), and the 
stomach (termed iPS-S) giving 16 lines (0.170%). Cm iPSCs could be maintained by primed culture conditions as 
Cm ESCs (see Supplementary Fig. S5). Alkaline phosphatase activity and the expression of pluripotency-related 
genes were confirmed (see Supplementary Fig. S5). Generally, the episomal vectors disappeared spontaneously 
during this process. However, iPS-L3 and iPS-S6 cell lines showed persistent expression of exogenous OCT3/4 
(see Supplementary Fig. S5). Actually, an episomal vector, pCXLE-hOCT3/4-shp53-F, was detected in iPS-L3, 
iPS-L6, and iPS-S6 cell lines by genomic PCR (see Supplementary Fig. S5). Generated iPSC lines showed a nor-
mal karyotype (2n = 42) at passages 10–20 (see Supplementary Table S1). When these iPSC lines were trans-
planted into severe combined immunodeficient mice, typical teratomas with all three primary germ layers 
were generated within 2 months after transplantation from all iPSC lines examined (see Supplementary Fig. S5 
and Table S3). Liver-derived iPSC lines (L3 and L6) and stomach-derived iPSC lines (S6 and S12) were sub-
jected to naïve-like conversion as ESCs. The colony morphology of naïve-like converted Cm iPSCs was dome 
shaped and positive for AP activity and naïve pluripotency-related proteins, as with naïve-like ESCs (Fig. 3a,c). 
Increased mRNA expressions of REX1, OCT3/4, GDF3, DPPA5, SOX2, TFCP2L1, and KLF4 were observed after 
naïve-like conversion of iPSCs (Fig. 3b). As with naïve-like ESCs, expression of endo-KLF2, endo-NANOG, and 
ESRRB did not increase in all converted iPS cell lines (Fig. 3b). However, unlike naïve-like CMK6 cells, the naïve 
pluripotency-related marker TBX3 did not increase with conversion. Exogenous hNANOG and hKLF2 were 
silenced in almost all iPSC lines examined (Fig. 3d). However, some remaining expression of Exo-hNANOG 
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Figure 2. Reactivity of LIF and mitochondrial alterations according to naïve-like conversion of Cm ESCs. 
(a) Phase contrast images (Phase), EOS-GFP, and CAG-Su9DsRed signals of naïve-like Cm ESCs cultured in 
the presence (K5cL medium) and the absence (K5c) of LIF. After withdrawal of LIF, cobble-stone-like colonies 
appeared, and faint EOS-GFP signals disappeared completely. Scale bar = 100 μ m. (b) Semi-quantitative RT–
PCR of naïve-like Cm ESCs before and after withdrawal of LIF. The mRNA expression of all examined naïve 
pluripotency-related genes decreased or disappeared after the withdrawal of LIF. (c and d) Puromycin resistance 
assay using naïve-like Cm ESCs before and after the withdrawal of LIF. Colony morphology and fluorescence 
signals are shown as images (c) and as quantitative evaluations (d). In the absence of LIF (–), almost all naïve-
like Cm ESCs disappeared with puromycin treatment. (e and f) Electron microscopic images (e) and their 
quantification (f) of the mitochondria in Cm ESCs before (bFGF/KSR) and after (K5cLD) naïve-like conversion. 
Before naïve-like conversion, primed-state ESCs contained more elongated mitochondria (arrowheads) than 
naïve-like converted cells. Scale bar = 1 μ m. (g) RT–qPCR of potential regulators involved in mitochondrial 
respiration, COX6b1, COX7a1, COX8c, NQO1, and cytochrome oxidase (COX)-associated mitochondrial protein 
(CAMP) before (bFGF/KSR medium, closed bars) and after (K5cLD medium, open bars) naïve-like conversion. 
All genes examined were upregulated by naïve-like conversion. (h and i) AP positive colony formation (h) and 
quantification (i) with 2-deoxyglucose (2DG) treatment. Scale bar = 1 cm. Within a week, almost all Cm ESCs in 
primed culture conditions (bFGF/KSR) disappeared in the presence of 4 mM of 2DG. (j) Graph of OCR changes in 
naïve-like ESCs and primed ESCs. Error bars indicate the S.D. *P < 0.05; **P < 0.01.
www.nature.com/scientificreports/
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Figure 3. Naïve-like conversion of Cm iPSC lines. (a) Phase contrast images (Phase) and the alkaline 
phosphatase activity (AP) signals of naïve-like Cm iPSCs. (b) RT–qPCR for naïve pluripotency-related transcripts 
before (closed bars: primed) and after (open bars: naïve-like) naïve-like conversion of a Cm ESC line, TRSK, and 
iPSC lines. Expression levels before (primed) and after naïve-like conversion of each cell line are standardized 
to 1.0. DPPA5 and endo-KLF2 indicate the relative expression level of ACTB (α -actin). Error bars indicate the 
S.D. *P < 0.05; **P < 0.01. (c) Immunocytochemical analysis of PSC lines (TRSK, iPS-L6, and iPS-S12) that had 
converted into a naïve-like state, using antibodies directed against markers of naïve pluripotency related proteins. 
(d) Relative expression of Exo-hNANOG and Exo-hKLF2 in the presence (K5cLD medium) and in the absence 
(K5cL medium) of Dox. (e) Teratoma formation of a naïve-like converted iPSC line, iPS-S12. Various tissues of the 
three germ layers are identified: neurons stained with HE (ectoderm), hyaline cartilage stained with Toluidine blue 
(mesoderm), and goblet cells stained with Alcian blue (endoderm). Scale bar = 100 μ m.
www.nature.com/scientificreports/
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was detected in a naïve-like converted ESC line, TRSK, and an iPSC line, iPS-S6. Teratomas able to form all three 
primary germ layers were also confirmed in all naïve-like converted iPSC lines (Fig. 3e, Supplementary Fig. S6, 
and Supplementary Table S3).
Transcriptomal analysis of Cm ESCs and iPSCs before and after naïve-like conversion. To 
ascertain whether naïve-like conversion was achieved successfully and to what degree it was accomplished, the 
transcriptome status of Cm PSCs cultured in bFGF/KSR (primed) medium, K5cLD (naïve-like) medium, and 
K5c medium (differentiated) was compared with that known for Cm embryos7. Unsupervised hierarchical clus-
tering (UHC) of Cm PSCs and the expression patterns of key genes are shown by a heat map (Fig. 4a). Principal 
component analysis (PCA) with all expressed genes in Cm PSCs was also done (Fig. 4b). These transcriptome 
evaluations suggested that PSCs in primed, naïve-like, and differentiated states could be classified according to 
their culture conditions. Although variation was observed in naïve-like PSCs, the transcriptome status of CMK6, 
TRSK, and iPS-S12 showed up-regulation of pluripotency-related and early embryo-related genes (Fig. 4a). To 
evaluate the relationship between Cm PSCs and the cells of Cm monkey epiblast (cyEPI) lineage, we examined 
the expression patterns of cyEPI ontogenic genes, which are able to delineate the stage along with the epiblast 
development precisely (Fig. 4c,d). Compared with naïve-like Cm ESCs17 or our primed-state PSCs, some of our 
naïve-like PSCs tended to resemble the expression profile of pre-implantation epiblast (Pre-EPI) cells. The cor-
relation coefficient for naïve-like CMK6 cells was high at 0.404. However, all of the naïve-like converted PSCs 
showed the closest correlation with post-implantation embryos, reflecting an incomplete conversion to the naïve 
state. These results indicated that our culture system partly succeeded in conversion of a primed state to a naïve 
state; however, it could not derive true naïve PSCs, which are known to show the expression profile closest to 
pre-implantation embryos.
Evaluation of chimera contribution by transferring naïve-like Cm ESCs into host 
embryos. Recently, naïve-like ESCs have been generated from Cm and could produce allogeneic chimeric 
embryos, albeit showing transcriptomal insufficiency compared with true naïve conversion17. To examine 
whether our naïve-like ESCs would contribute to interspecific chimeras as shown by Fang et al.18, they were 
injected into mouse pre-implantation embryos. When more than 10 naïve-like Cm ESCs were injected into mouse 
8-cell embryos, almost all the cultured embryos degenerated within 2 days after injection; however, when < 5 cells 
were injected into 8-cell embryos, 27/45 (60%) embryos developed to blastocysts (Fig. 5a and Table 1). The chi-
meric contribution of Cm ESCs to these mouse blastocysts was clearly shown by the presence of dark-brown cells 
with DsRed fluorescence (see Supplementary Fig. S8). However, failed or ambiguous integration to the embryos 
was observed when primed-state CMK6 was injected into 8-cell embryos, as done previously for primed-state 
rabbit PSCs12. When naïve-like Cm ESCs were injected into mouse 8-cell embryos (5 cells/embryo) and then 
transplanted into the oviducts of pseudopregnant host mothers, almost all the recovered embryos (25/28) had 
degenerated by the middle of pregnancy (12.5 dpc; see Supplementary Fig. S8 and Table 1). To ascertain when 
degeneration of interspecific Cm/mouse embryos occurred, 6.5-dpc interspecific chimeric embryos were recov-
ered from the uterus 6 days after transplantation. About a half (37/78; 47%) of the embryos had not implanted 
or had disappeared. The embryos retrieved were delayed developmentally at around the 5.5-dpc mouse embryo 
stage with hardly any ESC contribution (Fig. 5b–d). Actually, one 6.5-dpc interspecific chimeric embryo showing 
dark-brown cells with weak DsRed signals in the epiblast was also retarded (Fig. 5c).
When naïve-like Cm ESCs were injected into early mouse blastocysts (10 cells/embryo) and transplanted into 
mouse uteri, 37/77 (48%) of the transplanted embryos developed normally without any chimeric contribution 
even when they were recovered at an early post-implantation stage (6.5 dpc.). No evidence for chimeric con-
tribution (hair colour and DsRed signal) could be detected in any of the pups examined (Fig. 5e). These results 
suggested that when 8-cell mouse embryos were used as hosts, naïve-like Cm ESCs could contribute temporarily 
to interspecific chimeras. However, the contribution of Cm ESCs caused developmental impairment to mouse 
embryos at an early post-implantation stage, possibly because of species differences. On the other hand, when 
mouse blastocysts were used as recipients, almost all the host embryos could develop normally to term. Recently, 
Mashaki et al. revealed that E-CADHERIN (CDH1) and BCL2 play important roles in chimeric contribution 
by PSCs25. In this context, naïve-like CMK6 enhanced the expression of E-CADHERIN, but failed to express 
BCL2 (Fig. 1c). These results suggest that naïve-like CMK6 can contribute to pre-implantation embryos; however, 
naïve-like CMK6 underwent apoptosis as donor PSCs in recipient embryos. This could be why naïve-like ESCs 
could not survive in chimeric embryos. These results possibly reflect the limited temporal ability of naïve-like 
ESCs to contribute to chimeric embryos.
Naïve-like converted PSCs exhibited enhanced ability for in vitro neural differentiation. 
Previously, we have evaluated neural differentiation ability before and after naïve-like conversion of rabbit 
PSCs12,13. Rabbit PSCs show enhanced capacity for neural differentiation after naïve-like conversion. To eluci-
date the stem cell potential of Cm PSCs more precisely, an in vitro neural differentiation assay was also applied 
before and after naïve-like conversion. Naïve-like converted Cm ESCs reacted specifically to LIF and Dox (Fig. 2). 
To examine the sensitivity of LIF and Dox in naïve-like iPSCs, initial differentiation following the removal of 
these factors from the naïve-like iPSC culture conditions was evaluated. Within a week (one passage), almost 
all colonies of naïve-like ESCs formed a cobble-stone-like morphology (Figs 2a and 6a). However, naïve-like 
iPSC lines retained some dome-shaped colonies even after the removal of LIF and Dox (Fig. 6a,b). Hardly any 
differences in the mRNA expressions of pluripotency-related genes appeared between ESCs and iPSCs after the 
withdrawal of Dox and LIF (Fig. 6c and Supplementary Fig. S7). These results indicate that sensitivity to the 
removal of LIF and Dox reflects differences in the in vitro differentiating ability of naïve-like converted PSC lines. 
To ascertain whether naïve-like iPSCs would differentiate in a manner similar to naïve-like ESCs, we used an 
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Figure 4. Transcriptome evaluation of naïve-like Cm PSCs by SC3-seq. (a) UHC of Cm somatic cells and 
PSCs cultured in bFGF/KSR (primed medium), K5cLD (naïve-like medium), and K5c (differentiated medium) 
by all expressed genes (log2(RPM + 1) > 4 in at least one sample among PSC lines; 19,562 genes) and heat maps 
of the levels of selected marker genes. Colour bars under the dendrogram indicate the cell types (grey, somatic 
cells; red, naïve-like PSCs; blue, primed PSCs; green, differentiated). (b) PCA of PSCs cultured in bFGF/KSR 
(blue: primed), K5cLD (red: naïve-like), and K5c (green: differentiated). (c) Heat map of the expression of 776 
Cm EPI ontogenic genes in Cm embryos (ICM, Epiblast (Pre-, PostE-, and PostL-), Gastrulating (1, 2a, and 2b) 
and Cm ESCs (CMK6, TRSK, and CMK9) and Cm iPSCs cultured in bFGF/KSR (primed medium), K5cLD 
(naïve-like medium), and K5c (differentiated medium). (d) Heat map of the correlation coefficients among 
embryonic cells (Cm embryo), PSCs (primed, naïve-like), and those reported by refs 7 and 17. Correlation 
coefficients were calculated using the averaged expression levels of genes in (c).
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in vitro neural differentiation system for forming neurons and oligodendrocytes: the definitive assay for innate 
differentiation ability in PSCs12,13. We compared the in vitro neural differentiating ability of Cm ESCs (CMK6 and 
TRSK) and iPSCs (iPS-L3, iPS-L6, iPS-S6, and iPS-S12) before and after naïve-like conversion (Fig. 6d). The in 
vitro neural differentiation capacity of all these cell lines increased more than that of the primed-state PSCs. All 
of them effectively differentiated into oligodendrocytes with ramified branches, which were not observed even 
when primed-state cells differentiated (Fig. 6d). Although naïve-like ESCs showed a significantly enhanced dif-
ferentiation capacity, some of the naïve-like iPSC lines exhibited only limited differentiating ability (Fig. 6d and 
Supplementary Fig. S9). Transcriptome analysis revealed that candidate genes for neural progenitors (ZNF521, 
OTX2, ZIC2, SOX3, PAX6, and NES) did not tend to shift their expression profiles after conversion (Fig. 4a). 
Figure 5. Production of cynomolgus monkey and mouse interspecific chimeras. (a) Interspecific blastocysts 
generated 2 days after injection of naïve-like Cm ESCs (CMK6) into mouse 8-cell embryos. DsRed signals were 
observed in injected embryos. Mock: mock injected embryo. Scale bar = 100 μ m. (b) Evaluation of 6.5-dpc 
embryos. Almost all injected embryos retrieved were retarded in development without any DsRed signals. Scale 
bar = 500 μ m. (c) An injected embryo retardedly developed at 6.5 dpc showed Cm ESCs contribution as dark 
brown colour (black arrowhead) and weak DsRed signal (white arrowhead) in the epiblast. Scale bar = 500 μ m. 
(d) Comparison of embryo size of mock-injected and naïve-like ESC-injected embryos recovered at 6.5 dpc. (e) 
Detection of chimeric contribution by brown hair colour. No chimeric contribution was observed in any of the 
pups examined.
Cell line
Host embryos (injected cells/






(5) (10) oviduct uterus 6.5 dpc 12.5 dpc pups
CMK6
123 15 (9) (4) 95 (4/5) 23(0)/40 (21) 15(0)/35 (13) n.d.
135 118 (5/6) 30(0)/40 (8) 30(0)/38 (4) 13(0)/20 (4)
TRSK
95 12 (6) (6) 78 (3/4) 18(1)/38 (16) 13(0)/20 (12) n.d.
97 97 (4/5) 19(0)/37 (4) 10(0)20 (2) 12(0)/20 (4)
total 218 232 27 (15) (10) 173 (7/9) 215 (9/11) 90(1)/155 (49) 68(0)/113 (31) 25(0)/40 (8)
Table 1.  Generation of naïve-like Cm ESCs–mouse interspecific chimeras. n.d: not determined.
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Figure 6. Difference in in vitro differentiation potential between naïve-like ESCs and iPSCs. (a; left panels) 
Phase contrast images (Phase), tet-Venus (Venus), and CAG-DsRed (DsRed) signals of a naïve-like converted Cm 
ESC line, TRSK, before (K5cLD medium) and after (K5c medium) induction of in vitro differentiation. Almost all 
colonies showed a cobble-stone-like cell morphology (black arrowhead) within 10 days after the withdrawal of Dox 
and LIF. (a; right panels) Phase contrast images of the naïve-like converted Cm iPSC lines before (K5cLD medium) 
and after (K5c medium) the induction of in vitro differentiation. In contrast to ESCs, dome-shaped colonies (white 
arrowheads) remained after 10 days’ withdrawal of Dox and LIF. (b) Ratio of colony morphology of naïve-like ESCs 
and iPSCs before (K5cLD medium) and after (K5c medium) withdrawal of Dox and LIF. Open bars, dome-shaped 
colonies; closed bars, cobble-stone-like colonies. (c) Relative mRNA expression of pluripotency-related genes 
evaluated by RT–qPCR summarized for naïve-like Cm ESC lines (CMK6, TRSK, and CMK9) and naïve-like iPSC 
lines (iPS-L3, iPS-L6, iPS-S6, and iPS-S12) before and after withdrawal of Dox and LIF. (d) Immunocytochemical 
evaluation of the in vitro ability to differentiate into neurons (TUJ1) and oligodendrocytes (O1 and CNPase) before 
and after naïve-like conversion of Cm ESCs and iPSCs. Relative neural differentiation indices are shown for neurons 
immunostained for TUJ1 (top panels and top-right graph), oligodendrocytes marked by O1 (middle panels and 
middle-right graph) and CNPase (bottom panels and bottom-right graph) derived from Cm ESCs (CMK6, TRSK) 
and iPSCs (iPS-L3, iPS-L6, iPS-S6, iPS-S12). Closed bars, primed PSC-derived, open bars; naïve-like PSC-derived. 
Error bars indicate the S.D. *P < 0.05; **P < 0.01. Scale bar = 100 μ m.
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These results suggest that these naïve-like converted PSCs tended to accelerate their in vitro capacity for neural 
differentiation, despite only partial achievement of naïve conversion.
Discussion
Our study had four major findings. First, Cm PSCs could be converted into a naïve-like state with several char-
acteristics of naïve pluripotency including colony morphology, increased expression of pluripotency related 
genes, LIF dependency, and mitochondrial alterations. Second, transcriptome analysis based on pre- and 
post-implantation Cm embryos revealed that naïve-like converted PSCs had a transcriptomal status most resem-
bling that of post-implantation embryos but tended to shift to the status of pre-implantation embryos. Third, 
these naïve-like converted Cm ESCs failed to contribute to mouse embryos as interspecific chimeras and showed 
developmental retardation at just after the implantation stage. Finally, these naïve-like converted PSCs tended to 
accelerate their in vitro capacity for neural differentiation. To derive true naïve PSCs with higher differentiation 
potential and similar expression profiles to pre-implantation embryos could enable the ability to generate whole 
organs mainly constituted from donor PSCs in the host animal’s body26,27. Further examinations that focus on 
their transcriptomal status without miscellaneous naïve-like characteristics will be a key goal for deriving true 
naïve PSCs in non-human primates.
Several reports have demonstrated the conversion of primed human PSCs to a naïve (-like) state using different 
strategies15,16,28,29. The naïve status of PSCs in these reports was determined by several morphological and molec-
ular similarities to mouse ESCs7,14. However, because of the ethical impediments, one of the most stringent crite-
rions of true naïve pluripotency—the ability to contribute to chimeric embryos or pups—rarely been examined 
using naïve (-like) human PSCs. To determine their naïve pluripotency more precisely, their transcriptome status 
after naïve conversion should be assessed to evaluate whether they resemble those of human pre-implantation 
embryos. Actually, some human PSCs showed a transcriptome status resembling human pre-implantation 
embryos30,31. Here, naïve-like Cm ESCs barely remained in mouse embryos as interspecific chimeras at just after 
implantation, and they exhibited developmental blocks. Some reports have raised the possibility that the ability 
to contribute to chimera formation is not the best criterion of true naïve pluripotency. Actually, some human and 
non-human primate PSCs have demonstrated naïve-like conversion and also achieved the ability to contribute to 
interspecific chimeras17,28. However, transcriptome evaluations with these pre- and post-implantation embryos 
showed incomplete naïve-like conversion7,14. On the other hand, human naïve ESCs most resemble mouse ESCs 
and primate pre-implantation embryos but are only incorporated into mouse embryos as interspecific chimeras 
very inefficiently28. Interspecific chimera formation using PSCs has been achieved in the mouse and rat20,26,32. On 
the other hand, if truly naïve PSCs from other mammalian species could be generated successfully, it is not certain 
whether they could contribute to interspecific chimeras efficiently or not. Here, when Cm naïve-like ESCs were 
injected into mouse 8-cell embryos, almost all the chimeric embryos degenerated or were retarded around the 
implantation stage. These results imply that naïve-like Cm ESCs contributed temporarily to the mouse embryos 
but had negative effects at around 5.5–6.5 dpc. On the other hand, when mouse blastocysts were used as hosts, 
naïve-like Cm ESCs were barely incorporated at all, and the embryos developed normally without any develop-
mental impairments. These results suggest that the generation of chimeras using other mammalian PSCs needs 
to be examined, for not only the status of PSCs but also for host embryo compatibilities in terms of the species 
involved and their developmental stages.
Enhanced ability for in vitro neural differentiation was demonstrated after naïve-like conversion of Cm PSCs 
even if they did not completely reach true naïve pluripotency. We also found that these naïve-like ESCs showed 
superior capacity for oligodendrocyte differentiation than iPSCs. We demonstrated previously that naïve-like 
conversion enhances the difference in innate in vitro differentiation capacity between rabbit ES cells and iPS 
cells13. Almost no in vitro differentiation targets were achieved, other than the formation of germ cells, which can 
be generated more effectively in naïve PSCs than in primed PSCs6,12,13. Although evaluations of targeted in vitro 
differentiation potential with several target lineages before and after naïve conversion of human PSCs need to be 
demonstrated, the in vitro targeted induction of differentiation by confirming the potential for forming chime-
ras needs to be examined using experimental animals. Non-human primate PSCs, which transcriptionally most 
resemble pre-implantation epiblasts, are needed for assessing whether they can contribute effectively to chimeras, 
and can differentiate efficiently to desired target cell types in vitro.
In conclusion, we have attempted to convert primed-state Cm PSCs to a naïve state. Despite our confirma-
tion of several naïve characteristics, transcriptome evaluation suggested that they should be classified not as 
“true naïve state” but as having an incomplete “naïve-like” state. We have also elucidated that these naïve-like 
PSCs showed enhanced ability for in vitro neural differentiation. The achievement of true naïve conversion using 
non-human primate PSCs will lead to practical applications in human regenerative medicine.
Materials and Methods
Animals. All animals (Cm and ICR mice) were maintained and used for experiments in accordance with the 
guidelines for animal experimentation of the University of Miyazaki, RIKEN Bioresource Center, and Tsukuba 
Primate Research Center after obtaining approvals by the responsible committees of each institution.
Naïve-like conversion of Cm ESCs. The Cm ESC lines CMK6 (male), CMK9 (female), and TRSK (male) 
were used as reported33,34. To maintain their primed-state pluripotency, Cm ESCs were cultured in bFGF/KSR 
medium consisting of 78% Dulbecco’s modified Eagle’s medium/Ham’s F-12 (DMEM/F12) supplemented with 
15% KSR, 2 mM GlutaMax (Invitrogen Life Sciences, Carlsbad, CA, USA), 1% non-essential amino acids, 0.1 mM 
mercaptoethanol, and 4 ng/ml human recombinant bFGF (Wako, Osaka, Japan). To convert Cm ESCs into a 
naïve-like state, PiggyBac (PB) vectors carrying Dox-inducible hKLF2 or hNANOG coupled to Venus were 
cotransfected with a PB-EOS-GFP/puroR reporter, which has an rtTA expression construct15,20, and pCAG-PBase 
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using an NEPA21 electroporator (Nepa Gene Co., Ltd., Chiba, Japan). To confirm the chimeric contribution of 
ESCs into mouse embryos as interspecific chimeras, cell lines transfected with PB-CAG-Su9DsRediN were estab-
lished concurrently. One day after transfection, G418 (200 μ g/ml) and puromycin (250 ng/ml) were added to 
the selection in the presence of 1 μ M Dox. Two weeks after selection, transfectants were dissociated with trypsin 
digestion and replated and cultured in naïve-like conversion medium (K5cLD) consisting of 38% DMEM/F12 
and Neurobasal Medium supplemented with 20% KSR, 1% N2 supplement, 2% B27 supplement, 2 mM GlutaMax, 
1% non-essential amino acids (Invitrogen Life Sciences), 0.1 mM β -mercaptoethanol, 1% penicillin-streptomycin, 
and a five-chemical mix (5c): 5 μ M Gö6983, 10 μ M forskolin (Sigma-Aldrich, St. Louis, MO, USA), 5 μ M ken-
paullone, 3 μ M CHIR99021 (Stemgent Inc., Cambridge, MA, USA), 0.5 μ M SB590885 (Wako). Additionally, cell 
lines were evaluated in the presence or absence of 0.1% recombinant human LIF (L in media abbreviations; 
Wako) and 1 μ M Dox (D in media abbreviations; TaKaRa, Bio Inc., Shiga, Japan). K5cLD was changed daily, and 
cells were passaged using trypsin/EDTA by single cell dissociation and replated on mitomycin C-treated mouse 
embryonic fibroblast (MEF) feeder cells. To determine the appropriative culture conditions for Cm naïve conver-
sion, a culture medium used for rabbit cell naïve-like conversion12 was also assessed using K5cLD in the absence 
of Gö6983 and SB590885 (this medium was termed K3cLD).
To assess the culture media reported by Takashima et al.15, PB-tet-KLF2, PB-tet-NANOG, PB-EOS-GFP/puroR, 
and PB-CAG-Su9DsRediN were transfected into the Cm ESC line, CMK6, and cultured for 2 weeks in conven-
tional primed culture medium in the presence of 1 μ M Dox. According to Takashima et al., to derive Cm naïve 
PSCs, cultures were switched to t (titrated) 2iLD medium consisting of 48% DMEM/F12, 48% Neurobasal 
medium, 1% N2 supplement, 2% B27 supplement, 2 mM GlutaMax (Invitrogen Life Sciences), 0.1 mM 
β -mercaptoethanol, 1% penicillin-streptomycin, small molecules—1 μ M CHIR99021, and 1 μ M PD0325901—
(Stemgent), and 0.1% recombinant human LIF in the presence of Dox. Human-embryo-derived H9 cells that 
overexpressed NANOG and KLF2 genes were cultured in t2iLD medium for evaluating Cm naïve conversion.
To assess LIF-dependent maintenance of the naïve-like pluripotency of Cm ESCs, CMK6 and TRSK cell lines 
were cultured on DR4 feeder cells (Applied StemCell, Inc., Milpitas, CA, USA) expressing the puromycin resist-
ance gene. The culture medium used was K5cL (in the presence of LIF) or K5c (in the absence of LIF). Cells were 
treated with 0.5 μ g/ml of puromycin for 10 days.
iPS cell generation and culture. Cultured Cm somatic cells were trypsinized to disperse into single cells 
and electroporated with 10 μ g each of pCXLE-hOCT3/4-shp53-F, pCXLE-hUL, or pCXLE-hSK35 (Addgene, 
Cambridge, Massachusetts, USA) using a NEPA21 electroporator. Transfected cells were cultured at 37 °C under 
6% CO2 in air using DMEM supplemented with 10% foetal bovine serum, penicillin, and streptomycin. Eight 
days after transfection, cells were replated into 100-mm culture dishes and cultured using bFGF/KSR medium on 
MEF feeder cells at 37 °C under 6% CO2 in air. Twenty-six days after electroporation, iPS-like cell colonies were 
isolated mechanically and replated onto MEF feeder cells. Passaging of Cm iPSCs was performed by incubating 
the cells with phosphate buffered saline supplemented with 0.25% trypsin, 1 mg/ml collagenase type IV, 20% KSR, 
and 1 mM CaCl2. Fresh medium was changed daily, and cells were passaged every 3–4 days. To convert iPSCs into 
a naïve-like state, plasmids vectors for naïve-like conversion of Cm ESCs other than PB-CAG-Su9DsRediN were 
transfected and cultured as above. The Cm PSC lines used could be divided roughly into three categories of cell 
lines: embryonic stem (ES: CMK6 (male), CMK9 (female), and TRSK (male)); liver-derived iPS (iPS-L3, iPS-L6); 
and stomach-derived iPS (iPS-S6, and iPS-S12). After establishment, to confirm persistence of the remaining 
exogenous plasmid vectors, genomic DNA samples of all iPSC lines were subjected to genomic PCR using the 
specific primers listed in Supplementary Table S4.
Total RNA preparation and mRNA expression analysis. To avoid contamination from MEF feeder 
cells, Cm PSC lines (CMK6, TRSK, CMK9, iPS-L3, iPS-L6, iPS-S6, and iPS-S12) were cultured for more than two 
passages on MEF-free culture plates coated with laminin-511 (Wako). Total RNA was isolated with RNeasy Plus 
mini kits (QIAGEN, Hilden, Germany) from cells cultured under the appropriate conditions. After QIAshredder 
(QIAGEN) treatment to prevent contamination with genomic DNA, the first-strand cDNA was synthesized using 
RNA PCR kits (TaKaRa Bio Inc.) for reverse transcriptase polymerase chain reaction (RT–PCR). The synthesized 
cDNA was amplified by PCR using the specific primers listed in Supplementary Table S4, with a cycling program 
of 94 °C for 3 min and 35 cycles of 94 °C for 30 s, 60 °C for 30 s, and 72 °C for 30 s. For RT–qPCR, a LightCycler 96 
(Roche Applied Sciences, Mannheim, Germany) was used to determine mRNA expression levels using the Fast 
Start Essential DNA Green Master Mix (Roche Applied Sciences), with a program of 94 °C for 10 min, 40 cycles 
of 94 °C for 10 s, 60 °C for 10 s, and 72 °C for 10 s.
Transcriptome analysis by SC3-Seq. Total RNAs of Cm ESCs (CMK6, TRSK, CMK9) and iPSCs (iPS-L3, 
L6, S6, S12), cultured in bFGF/KSR (primed), K5cLD (naïve-like), or K5c (differentiated) media, were prepared 
as above. Total RNAs of Cm somatic cells from the liver and stomach were also prepared. cDNA synthesis and 
the construction of a SC3-seq library were carried out as reported7,36. Briefly, cDNA was synthesized from 1 ng 
of total RNA s and evaluated for quality using an ERCC RNA Spike-In Mix (Ambion #4456740; Thermo Fisher 
Scientific). SC3-seq libraries of quality-checked cDNAs were constructed and sequenced using a Nextseq500 sys-
tem (Illumina, San Diego, CA, USA; 75 bp, single read; FC-404-2005). Expression levels were converted using cuf-
flinks v. 2.2.037 with the “-compatible-hits-norm-library-type fr-unstranded-max-mle-iterations 50000” options. 
We defined expressed genes as those whose log2 (RPM + 1) values were > 4 or greater than ~10–20 copies per cell, 
which is a lower limit for reliable and reproducible detection by the single-cell cDNA amplification method7,36 in 
at least one sample. UHC was performed using the “hclust” function with Euclidian distances and Ward’s method 
(ward.D2). PCA was performed using the “prcomp” function without scaling. Gene expression of the PSCs in 
several culture conditions were compared with those of Cm embryos in the undifferentiated inner cell mass 
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(ICM), pre-implantation epiblasts (Pre-EPI), post-implantation early epiblasts (PostE-EPI), post-implantation 
late epiblasts (PostL-EPI), and gastrulating cells 1, 2a, and 2b (Gast1, 2a, and 2b)7.
Evaluation of chimeric contribution to mouse embryos. To evaluate whether the naïve-like Cm ESCs 
could contribute to mouse embryos and pups as interspecific chimeras, naïve-like CMK6 or TRSK cells were 
trypsinized to dissociate into single cells. Recipient embryos were obtained by in vitro fertilization using super-
ovulated ICR strain mouse oocytes and ICR sperm in human tubal fluid medium (ARK Resource, Kumamoto, 
Japan) and then cultured in potassium simplex optimized medium (ARK Resource) to develop into 8-cell stage 
embryos or blastocysts. Naïve-like CMK6 or TRSK cells (n = 5–10) were injected into the perivitelline spaces of 
8-cell embryos or blastocoels of the blastocysts using a Piezo-driven micromanipulator (Prime Tech Ltd., Ibaraki, 
Japan). Interspecific 8-cell embryos or blastocysts were transplanted into the oviducts or uteri of pseudopregnant 
ICR mice, respectively. Early post-implantation (5.5- and 6.5-dpc) embryos were recovered and observed using a 
fluorescence microscope, MVX10 (Olympus, Tokyo, Japan). Chimerism of any embryos or neonates was deter-
mined by the presence of DsRed signals and brown hair colour.
In vitro neural differentiation. As reported12,13 to induce neural differentiation, Cm PSC lines were 
digested with trypsin, suspended in embryoid body (EB) medium containing 78% DMEM/F-12 supple-
mented with 20% KSR, 1% non-essential amino acids, 50 units/ml penicillin, 50 μ g/ml streptomycin, 0.1 mM 
β -mercaptoethanol, 1% N2 supplement, 4 μ M all-trans-retinoic acid (Sigma-Aldrich), and 10 μ M SB431542 
(Tocris Bioscience, Bristol, UK). To achieve single EBs of a uniform size, 1,000 PSCs in a volume of 100 μ l 
were dispensed into each well of low-cell-adhesion 96-well round-bottomed plates (Thermo Fisher Scientific, 
Waltham, MA, USA), tapped gently, and cultured at 37 °C under 6% CO2 in air. To obtain differentiated oli-
godendrocytes, six EBs were transferred to matrigel-coated (BD Biosciences, Franklin Lakes, NJ, USA) 4-well 
multi-dishes (Nunc) and allowed to attach to the bottoms of the wells. The medium was then changed from EB 
medium to neural differentiation medium (the same formulation as EB medium, with the addition of 10% KSR). 
After 10 days, the medium was changed from neural differentiation medium to the culture medium without reti-
noic acid or SB431542 but with 100 ng/ml Noggin (Wako). The cells were cultured for a further 20 days, with fresh 
medium changed every day. After in vitro neural differentiation, cells were immunochemically stained using the 
neural antibodies anti-TUJ1, anti O1, and anti-CNPase.
Statistical analysis. Mean values were compared using one-way analysis of variance (ANOVA). Where 
appropriate, the significance of differences in the means was determined with Fisher’s exact probability test. 
P < 0.05 was considered to be significant. All experiments were analysed at least in triplicate.
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